Immunotherapy for noninfectious diseases

The designation of the immune system is the maintenance of both internal environment and structural integrity of the body. Not only anti-infectious protection, but also anticancer defense is attributable to the immune-mediated sphere. Therefore,. the antitumor immunotherapy must be a basic component in the systemic treatment for malignancy . The selectivity of cytoreductive action and the possibility of achieving a long-lasting antitumor effect are the apparent advantages of the immunotherapy over other forms of the system treatment for more information

Autoimmune diseases are consequences of the pathological activity of self-reactive lymphocytes. A main disadvantage of the base therapy for those diseases, that is in common practice to date, is the absence of selectivity in its immunodepressive action. This therapy suppresses not only pathologic autoimmune processes, but also all “useful” immune functions. Obviously, that the progress in the treatment for autoimmune diseases will be connected with the development of immunotherapeutic approaches selectively directed toward the selective inactivation of precisely those immunocompetent cells, which are implicated in the pathologic process for more information.

The maintenance of both internal environment and structural integrity of the body would be impossible without existing physiological and reparative tissue regeneration. Metabolic abnormalities are the relatively early manifestations of regenerative insufficiency of the body Evidence accumulating during the last decade indicates that the immune system is responsible for implicating stem cells in the regenerative processes, as well as for realizing their differential potential. Immunoregenerative therapy for metabolic abnormalities is destined for inhibiting the development of degenerative tissue changes leading to age-related diseases for more information.